In focus · trending topic

Susan Catalano

2 stories · following the connections

Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting

By Nasdaq OMXMar 14, 2018, 2:33 PM UTC

Cognition Therapeutics Co-Founder and CSO Susan Catalano to Present at Sachs Neuroscience Innovation Forum

By Nasdaq OMXJan 4, 2018, 1:05 PM UTC